Literature DB >> 28589412

Serum CTX levels and histomorphometric analysis in Src versus RANKL knockout mice.

Sunao Takeshita1, Toshio Fumoto2, Masako Ito3, Kyoji Ikeda2.   

Abstract

Src knockout (KO) and RANKL KO mice both exhibit near complete osteopetrosis in terms of 3D-bone volume (BV) fraction by micro-CT, whereas the serum CTX concentration of Src KO is apparently normal and that of RANKL KO is 30% of wild-type (WT) despite the fact that they lack osteoclasts. By histomorphometry we found that, whereas eroded surface (ES) and osteoid surface (OS) are zero values in RANKL KO, they are indistinguishable from WT in Src KO; because of marked increase in bone surface (BS), ES/BS and OS/BS of Src KO are 30-40% of WT. While RANKL KO lack both osteoclasts and osteoblasts, Src KO reveal increased numbers of osteoclasts and indistinguishable numbers of osteoblasts compared with WT; again, on the basis of BS, N.Oc/BS is comparable to WT and N.Ob/BS is markedly decreased in Src KO. The apparently increased number of total osteoclasts may be due to increased expression of RANKL found in Src KO bone in vivo. Src has a gene dosage-dependent effect on osteoclast function in vitro, with Src-/- osteoclasts completely lacking bone-resorbing function as determined by CTX release on dentin. Thus, Src KO osteoclasts retain some bone-resorbing function in vivo. The number of osteocytes is proportionally increased in RANKL KO, while Src KO mice have relative osteocyte deficiency, raising the possibility that RANKL and Src has an unrecognized role in osteocyte survival.

Entities:  

Keywords:  Osteoblast; Osteoclast; Osteocyte; Osteopetrosis

Mesh:

Substances:

Year:  2017        PMID: 28589412     DOI: 10.1007/s00774-017-0838-3

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  18 in total

1.  Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.

Authors:  S Takeshita; K Kaji; A Kudo
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

Review 2.  Osteoclast activity and subtypes as a function of physiology and pathology--implications for future treatments of osteoporosis.

Authors:  K Henriksen; J Bollerslev; V Everts; M A Karsdal
Journal:  Endocr Rev       Date:  2010-09-17       Impact factor: 19.871

3.  Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.

Authors:  Masako Ito; Keiji Nakayama; Akira Konaka; Kiyoto Sakata; Kyoji Ikeda; Takayuki Maruyama
Journal:  Bone       Date:  2006-04-03       Impact factor: 4.398

Review 4.  Molecular mechanisms in coupling of bone formation to resorption.

Authors:  T Martin; Jonathan H Gooi; Natalie A Sims
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

5.  Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

Authors:  V Iotsova; J Caamaño; J Loy; Y Yang; A Lewin; R Bravo
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

Review 6.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

7.  c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling.

Authors:  Barbara Peruzzi; Alfredo Cappariello; Andrea Del Fattore; Nadia Rucci; Fabrizio De Benedetti; Anna Teti
Journal:  Nat Commun       Date:  2012-01-17       Impact factor: 14.919

8.  Bone and haematopoietic defects in mice lacking c-fos.

Authors:  Z Q Wang; C Ovitt; A E Grigoriadis; U Möhle-Steinlein; U Rüther; E F Wagner
Journal:  Nature       Date:  1992 Dec 24-31       Impact factor: 49.962

9.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

10.  Decreased c-Src expression enhances osteoblast differentiation and bone formation.

Authors:  M Marzia; N A Sims; S Voit; S Migliaccio; A Taranta; S Bernardini; T Faraggiana; T Yoneda; G R Mundy; B F Boyce; R Baron; A Teti
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.